Cargando…
Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus
The Middle East respiratory syndrome coronavirus (MERS-CoV) was first isolated in 2012, and circulated worldwide with high mortality. The continual outbreaks of MERS-CoV highlight the importance of developing antiviral therapeutics. Here, we rationally designed a novel fusion inhibitor named MERS-fi...
Autores principales: | Sun, Yaping, Zhang, Huaidong, Shi, Jian, Zhang, Zhe, Gong, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618021/ https://www.ncbi.nlm.nih.gov/pubmed/28906430 http://dx.doi.org/10.3390/v9090255 |
Ejemplares similares
-
Antibodies and vaccines against Middle East respiratory syndrome coronavirus
por: Xu, Jiuyang, et al.
Publicado: (2019) -
Vaccine against Middle East respiratory syndrome coronavirus
por: Shen, Xuejuan, et al.
Publicado: (2019) -
Vaccine against Middle East respiratory syndrome coronavirus
por: Zumla, Alimuddin, et al.
Publicado: (2019) -
Novel Middle East respiratory syndrome coronavirus
por: Wiwanitkit, Viroj
Publicado: (2014) -
Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus
por: Payne, Daniel C., et al.
Publicado: (2016)